Respiratory Inhalers Market Size & Growth | Statistics Report 2028
呼吸吸入器市场预计将从 2022 年的 311.4456 亿美元增长到 2028 年的 434.4619 亿美元;预计 2022 年至 2028 年的复合年增长率为 5.7%。
呼吸吸入器用于吸入药物,这是治疗慢性肺部疾病必不可少的一部分。它们既可用于预防,也可用于治疗这些慢性疾病的恶化。它们的优点是避免全身性药物暴露,同时确保药物直接到达肺部。许多产品将药物直接输送到呼吸道,例如干粉吸入器、定量吸入器 (MDI)、雾化器和软雾吸入器。由于哮喘、慢性阻塞性肺病 (COPD)、囊性纤维化、哮喘-COPD 重叠综合征等呼吸系统疾病的患病率不断上升,呼吸吸入器市场预计将增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
呼吸吸入器市场:
复合年增长率(2022 - 2028)5.7%- 2022 年市场规模
311.4 亿美元 - 2028 年市场规模
434.5 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 阿斯利康公司
- 贝希姆科制药有限公司
- 勃林格殷格翰国际有限公司
- 西普拉有限公司
- 葛兰素史克公司
- 荷兰皇家飞利浦公司
- 欧姆龙公司
- PARI 呼吸设备有限公司
- 梯瓦制药工业有限公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 雾化器
- 定量吸入器
- 手动吸入器和电子吸入器
- 哮喘
- 慢性阻塞性肺疾病
- 肺动脉高压
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
呼吸吸入器市场洞察
通用吸入器的日益普及推动了呼吸吸入器市场的增长
吸入药物涉及多种吸入装置,是哮喘和 COPD 药物治疗的主要手段。哮喘和 COPD 患者通常每天需要使用一个或多个吸入器来保持呼吸道健康。因此,医疗保健专业人员担心药物切换可能会通过低依从性和气雾剂输送装置类型的滥用对疾病控制产生负面影响。随着医疗保健预算压力的增加以及现有吸入治疗专利的到期,全球范围内正在制造和供应多种仿制替代产品。用于治疗哮喘的几种吸入剂包括仿制药,例如沙丁胺醇、左沙丁胺醇、异丙托溴铵、布地奈德和氟替卡松/沙美特罗。仿制药吸入器与品牌吸入器具有生物等效性,对身体具有相同的效果。随着专利到期,仿制药哮喘吸入器的数量继续增加。 2020 年 3 月 3 日,美国食品药品管理局 (FDA) 批准了仿制哮喘吸入器和仿制吸入性皮质类固醇粉。2020 年 4 月,FDA 批准了一种基于硫酸沙丁胺醇的仿制吸入器,以满足呼吸困难的 COVID-19 患者的需求。随着越来越多的仿制药进入市场,预计竞争将加剧,从而导致药品成本降低。推出“获批仿制药”也可以降低成本。因此,仿制吸入器和哮喘药物的日益普及正在提高药物依从性,从而推动 呼吸吸入器市场的发展
基于产品类型的洞察
根据产品类型,呼吸吸入器市场细分为雾化器、定量吸入器和干粉吸入器。干粉吸入器细分市场进一步分为多剂量干粉吸入器和单剂量干粉吸入器。定量吸入器 (MDI) 细分市场进一步分为压力定量吸入器和连接定量吸入器。雾化器细分市场细分为压缩空气雾化器、网状空气雾化器和超声波空气雾化器。2022 年,干粉吸入器细分市场占据最大市场份额。然而,预计定量吸入器 (MDI) 细分市场在预测期内的复合年增长率最高。
基于技术的见解
根据技术,呼吸吸入器市场分为手动吸入器和数字吸入器。手动吸入器部分在 2022 年占据了更大的市场份额,预计在预测期内将实现更高的复合年增长率。
呼吸吸入器市场报告范围
报告属性 | 细节 |
---|---|
2022 年市场规模 | 311.4亿美元 |
2028 年市场规模 | 434.5亿美元 |
全球复合年增长率(2022 - 2028) | 5.7% |
历史数据 | 2020-2021 |
预测期 | 2023-2028 |
涵盖的领域 | 按产品类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
基于疾病指征的见解
根据疾病指征,全球呼吸吸入器市场分为哮喘、慢性阻塞性肺病、肺动脉高压等。哮喘领域在 2022 年占据了最大的市场份额,预计在预测期内将以最高的复合年增长率增长。
呼吸吸入器市场中的公司普遍采用并购等无机和有机战略。以下列出了一些近期的关键市场发展:
- 2022 年 9 月,Beximco Pharmaceuticals 推出了 ONRIVA TRIO BEXICAP,这是一种干吸入胶囊。ONRIVA TRIO BEXICAP 是茚达特罗 (150 µg)、格隆铵 (50 µg) 和莫米松 (160 µg) 的制剂。它通过三种方式控制哮喘症状。茚达特罗和格隆铵帮助肺气道肌肉保持放松以防止支气管收缩,而莫米松则有助于减少炎症。ONRIVA TRIO BEXICAP 适用于严重持续性哮喘的维持治疗。
- 2021 年 6 月,Cipla 宣布其 Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL 的简化新药申请 (ANDA) 已获得美国食品药品管理局的最终批准。Cipla 的 Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL 是 Sunovion Pharmaceuticals Inc. 的 Brovana 的 AN 级仿制药治疗等效版本。
- 2022 年 2 月,阿斯利康和霍尼韦尔宣布计划合作开发使用推进剂 HFO-1234ze 的下一代呼吸吸入器,该推进剂的全球变暖潜能值 (GWP) 比目前呼吸药物中使用的推进剂低 99.9%。
- 2023 年 1 月,FDA 在美国批准 Airsupra [加压定量吸入器 (pMDI)] 用于按需治疗或预防支气管收缩。Airsupra 是美国首创的加压定量吸入器 (pMDI),固定剂量组合救援药物,含有短效 β2 激动剂 (SABA) 沙丁胺醇和抗炎吸入皮质类固醇 (ICS) 布地奈德。
公司简介
- 阿斯利康公司
- 贝希姆科制药有限公司
- 勃林格殷格翰国际有限公司
- 西普拉有限公司
- 葛兰素史克公司
- 荷兰皇家飞利浦公司
- 欧姆龙公司
- PARI 呼吸设备有限公司
- 梯瓦制药工业有限公司
- OPKO 健康公司
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Companies operating in the market are AstraZeneca Plc, Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH, Cipla Ltd.;GSK Plc, Koninklijke Philips NV, OMRON Corp, PARI Respiratory Equipment, Inc.; Teva Pharmaceutical Industries Ltd.; and OPKO Health, Inc..
Global respiratory inhalers market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the respiratory inhalers market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.
Based on technology, the global respiratory inhalers market is divided into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held the largest share of the market in 2022 and is expected to grow at the highest CAGR during the forecast period.
The respiratory inhalers market, by product type, is segmented into nebulizers, metered dose inhalers, and dry powder inhalers. The dry powder inhalers segment held the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period (2022–2028).
Key factors driving the market growth are rising cases of respiratory disorders and growing adoption of generic inhalers.
Respiratory inhalers are used to inhale drugs that are an essential part of treating chronic lung diseases. They are used both to prevent and treat exacerbations of these chronic diseases. They offer the advantage of avoiding systemic drug exposure while ensuring the drugs reach the lungs directly. Numerous products deliver drugs directly into the airways, such as dry powder inhalers, metered dose inhalers (MDIs), nebulizers and soft mist inhalers. The respiratory inhaler market is expected to flourish due to the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, asthma-COPD overlap syndrome, and others.
The List of Companies - Respiratory Inhalers Market
- AstraZeneca Plc
- Beximco Pharmaceuticals Ltd.
- Boehringer Ingelheim International GmbH
- Cipla Ltd.
- GSK Plc
- Koninklijke Philips NV
- OMRON Corp
- PARI Respiratory Equipment, Inc.
- Teva Pharmaceutical Industries Ltd.
- OPKO Health, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.